Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Aarti Drugs Ltd

Pharmaceuticals & Biotechnology | Small Cap

Aarti Drugs Ltd Health Insights
Health Score : 5.07Health Score : 5.07

Aarti Drugs Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient management of assets. Its coverage ratios also reflect a robust ability to meet its financial obligations. However, the company faces challenges in liquidity, efficiency, and growth. Decreasing revenue, operating profit, and EPS growth suggest potential market pressures or internal inefficiencies. Low liquidity ratios implies the company might face difficulty in meeting its short-term obligations. While the company's asset growth is a positive sign, its overall financial health is moderate due to the mentioned weaknesses.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025-26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Aarti Drugs Ltd Health Insights
Health Score : 5.07Health Score : 5.07

Aarti Drugs Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, indicating a solid foundation and efficient management of assets. Its coverage ratios also reflect a robust ability to meet its financial obligations. However, the company faces challenges in liquidity, efficiency, and growth. Decreasing revenue, operating profit, and EPS growth suggest potential market pressures or internal inefficiencies. Low liquidity ratios implies the company might face difficulty in meeting its short-term obligations. While the company's asset growth is a positive sign, its overall financial health is moderate due to the mentioned weaknesses.

Latest Report

View All
Quarterly Financial Results Q3 FY 2025-26

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Undervalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Undervalued

P/E RATIO (TTM)

19.98

Undervalued

Industry Median

28.62

Undervalued
Undervalued

Small Cap Median

27.17

Undervalued

P/E RATIO

17.34

P/B RATIO

2.18

Undervalued

Industry Median

3.17

Undervalued
Neutral

Small Cap Median

2.62

Neutral

P/S RATIO

1.43

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Highly Undervalued

PEG RATIO

-2.48

Highly Undervalued
Overvalued

EV/EBITDA RATIO

12.52

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹370.35 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report3rd Feb 26

Quarterly Financial Results Q3 FY 2025-26

NEUTRAL SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.80

The growth metrics present a mixed picture, with strong asset growth offset by declines in revenue, operating profit, and EPS. This indicates potential challenges in translating asset growth into profitable revenue streams. Focus on strategic investments and market expansion could help improve overall growth. A positive growth rate is generally preferred.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate15.59.12-6.89-5.617.46
Operating Profit Growth Rate-24.32-7.213.88-9.666.55
Earnings Per Share (EPS) Growth-26.42-18.883.84-1.2315.96
Asset Growth Rate25.039.650.455.889.32
Net Income Growth Rate-26.79-19.023.61-2.3316.07
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.40

The financial metrics indicate challenges in key areas such as earnings per share, book value, and capital expenditures. Low adjusted EPS and cash EPS suggest potential profitability issues, while a low book value per share may reflect limited equity value. Careful management of capital expenditures is necessary to ensure efficient resource allocation. Higher values for EPS and Book Value are generally preferred.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)22.0417.8518.718.4621.43
Cash Earnings Per Share (Cash EPS)27.4223.2324.2424.6228.79
Book Value Per Share111.51128.28139.35150.44170.22
Dividend Per Share (DPS)1.111.080.930.920
Capital Expenditures (CapEx)152165226177173
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The profitability metrics demonstrate strong performance across various measures. High gross profit margins, ROCE, ROE, ROA, operating margin, and net margin indicate efficient operations and effective cost management. Maintaining these profitability levels is crucial for long-term success. Higher values for all the profitability ratios are generally preferred.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin11.379.5410.689.89.43
Return on Capital Employed (ROCE)2115151312
Return on Equity (ROE)19.7713.9113.4212.2712.59
Return on Assets (ROA)15.0812.7613.211.2610.98
Operating Margin13.3811.3812.6912.1512.05
Net Margin8.246.116.87.047.6
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.00

The efficiency metrics point towards inefficiencies in asset utilization and working capital management. Low turnover ratios and extended collection periods suggest that the company is not effectively leveraging its assets to generate revenue. Addressing these inefficiencies can improve profitability and free up capital for reinvestment. Higher turnover ratios are typically preferred as they indicate efficient use of assets for generating revenue.

WeakFixed Asset Turnover RatioWeak
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio3.614.023.122.762.36
Inventory Turnover Ratio4.694.724.514.494.82
Receivables Turnover Ratio3.813.363.223.283.24
Days Sales in Inventory Ratio77.8377.3380.9381.2975.73
Receivable Days95.8108.63113.35111.28112.65
Capital Turnover Ratio2.111.941.621.441.42
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The coverage ratios demonstrate a strong ability to meet interest and dividend obligations. High-interest coverage indicates a comfortable margin for servicing debt, while a high equity dividend coverage suggests a strong capacity to reward shareholders. This provides financial flexibility and reduces the risk of financial distress. A higher value is generally preferred for both the ratios.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio12.257.057.216.447.21
Equity Dividend Coverage Ratio2016.672020
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The solvency position indicates strong financial stability and a low risk of financial distress. Conservative debt levels and a high proportion of equity in the capital structure provide a solid foundation for long-term sustainability. This allows the company to pursue growth opportunities without undue financial strain. A lower debt ratio is generally preferred as it indicates lesser dependence on borrowed funds.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.120.150.180.170.14
Debt to Equity Ratio0.140.180.220.20.16
Equity Ratio0.880.850.820.830.86
Debt To Asset Ratio0.060.090.110.110.09
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 4.26

The liquidity position indicates challenges in meeting short-term obligations. While the quick ratio suggests an ability to cover immediate liabilities, low cash and operating cash flow ratios raise concerns about the availability of liquid assets. This necessitates careful monitoring of working capital to ensure operational needs are met. The current ratio indicates the company's ability to pay its short term obligation with its current assets. A higher current ratio indicates better liquidity position of the company.

WeakCurrent RatioWeak
AverageQuick RatioAverage
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.381.481.531.481.48
Quick Ratio0.870.980.980.960.99
Cash Ratio0.020.010.010.010.01
Operating Cash Flow Ratio0.070.130.410.270.25
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 20 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
2Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
3Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
4Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
5Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
6RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
7Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
8Alembic Ltd7.067.28Undervalued90.004.85317.00
9SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
10Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
11Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
12IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
13Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
14Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
15Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
16Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
17Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
18Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
19Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

The management of Aarti Drugs demonstrates a mixed performance. Strengths include consistent dividend payouts and relatively stable operating profit margins. However, there are notable weaknesses such as declining sales and profit growth, along with decreasing promoter holding. Increased debt levels also impact financial leverage. Overall, the management's effectiveness is mixed, suggesting areas needing improvement in growth and financial strategies.

Category Metric Value Assessment
PROS Dividend Payout % 5% Consistent sharing of profits
OPM % (Avg) 12% Stable operating profit margin
CONS Sales Growth (3Y) -1% Declining sales growth
Profit Growth (3Y) -6% Declining profit growth
Promoter Holding 55.48% Decreasing promoter confidence
Debt/Equity Ratio 0.45 Increased financial leverage
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Aarti Drugs faces moderate risk due to increasing debt and decreasing sales and profit growth, potentially leading to financial strain. However, a consistent dividend payout and stable operational efficiency offer some stability. Monitoring financial leverage and strategic responses to growth challenges are essential to mitigate risks.

AverageAccounting quality red flagsAverage
AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
01.

Accounting quality red flags

02.

Segment performance volatility

03.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10371.32Bearish
  3. SMA 20371.20Bearish
  4. SMA 50371.43Bearish
  5. EMA 10370.96Bearish
  6. EMA 20371.36Bearish
  7. EMA 50372.27Bearish
  8. DEMA 10370.31Bearish
  9. DEMA 20370.88Bearish
  10. DEMA 50370.29Bearish
  11. TEMA 10369.85Bullish
  12. TEMA 20370.69Bearish
  13. TEMA 50370.83Bearish
  14. MACD-0.42Bearish
  15. ADX21.44Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.29Neutral
  3. CCI-28.00Neutral
  4. ROC 9-1.07Bearish
  5. ROC 140.68Bullish
  6. ROC 25-0.59Bearish
  7. Stoch K20.16Neutral
  8. Stoch D19.36Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper376.68Neutral
  3. BB Middle371.20Neutral
  4. BB Lower365.72Neutral
  5. ATR3.44Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI42.61Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10370.69Bearish
  3. SMA 20371.57Bearish
  4. SMA 50372.89Bearish
  5. EMA 10370.75Bearish
  6. EMA 20371.23Bearish
  7. EMA 50373.41Bearish
  8. DEMA 10370.34Bearish
  9. DEMA 20370.14Bearish
  10. DEMA 50370.12Bearish
  11. TEMA 10370.26Bearish
  12. TEMA 20370.58Bearish
  13. TEMA 50368.56Bullish
  14. MACD-0.78Bullish
  15. ADX20.28Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.70Neutral
  3. CCI-51.98Neutral
  4. ROC 90.61Bullish
  5. ROC 14-0.35Bearish
  6. ROC 250.56Bullish
  7. Stoch K18.26Oversold
  8. Stoch D22.72Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper376.40Neutral
  3. BB Middle371.57Neutral
  4. BB Lower366.73Neutral
  5. ATR4.58Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI45.50Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10371.02Bearish
  3. SMA 20371.27Bearish
  4. SMA 50377.19Bearish
  5. EMA 10370.61Bearish
  6. EMA 20372.12Bearish
  7. EMA 50374.33Bearish
  8. DEMA 10369.52Bullish
  9. DEMA 20369.11Bullish
  10. DEMA 50374.92Bearish
  11. TEMA 10369.89Bullish
  12. TEMA 20368.70Bullish
  13. TEMA 50N/AN/A
  14. MACD-2.13Bullish
  15. ADX15.00Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.03Neutral
  3. CCI-62.21Neutral
  4. ROC 9-0.82Bearish
  5. ROC 14-0.67Bearish
  6. ROC 25-1.45Bearish
  7. Stoch K23.35Neutral
  8. Stoch D27.02Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper377.81Neutral
  3. BB Middle371.27Neutral
  4. BB Lower364.73Neutral
  5. ATR7.21Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.40Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10370.84Bearish
  3. SMA 20377.61Bearish
  4. SMA 50375.26Bearish
  5. SMA 100368.38Bullish
  6. SMA 200412.15Bearish
  7. EMA 10371.96Bearish
  8. EMA 20374.11Bearish
  9. EMA 50373.90Bearish
  10. EMA 100379.67Bearish
  11. EMA 200398.39Bearish
  12. DEMA 10369.20Bullish
  13. DEMA 20372.06Bearish
  14. DEMA 50373.68Bearish
  15. DEMA 100361.17Bullish
  16. DEMA 200365.76Bullish
  17. TEMA 10368.92Bullish
  18. TEMA 20368.44Bullish
  19. TEMA 50379.78Bearish
  20. TEMA 100367.18Bullish
  21. TEMA 200354.72Bullish
  22. MACD-1.90Bearish
  23. ADX11.89Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI46.51Neutral
  3. CCI-70.86Neutral
  4. ROC 14-3.28Bearish
  5. ROC 252.21Bullish
  6. Stoch K19.06Oversold
  7. Stoch D17.50Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper394.94Neutral
  3. BB Middle377.61Neutral
  4. BB Lower360.29Neutral
  5. ATR11.47Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI57.27Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20367.20Bullish
  3. SMA 50424.87Bearish
  4. EMA 20378.26Bearish
  5. EMA 50403.01Bearish
  6. DEMA 20362.61Bullish
  7. DEMA 50370.18Bullish
  8. TEMA 20369.67Bullish
  9. TEMA 50357.72Bullish
  10. MACD-9.62Bullish
  11. ADX10.09Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI45.22Neutral
  3. CCI-63.28Neutral
  4. ROC 144.09Bullish
  5. ROC 25-2.58Bearish
  6. Stoch K65.00Neutral
  7. Stoch D69.82Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper396.86Neutral
  3. BB Middle367.20Neutral
  4. BB Lower337.55Neutral
  5. ATR26.71Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.28Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6372.69Bullish
  3. SMA 12422.75Bearish
  4. SMA 24436.63Bearish
  5. EMA 6381.23Bearish
  6. EMA 12401.32Bearish
  7. EMA 24424.66Bearish
  8. DEMA 6361.70Bullish
  9. DEMA 12371.38Bullish
  10. DEMA 24394.14Bearish
  11. TEMA 6361.77Bullish
  12. TEMA 12360.63Bullish
  13. TEMA 24370.44Bullish
  14. MACD-6.85Bearish
  15. ADX13.60Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI47.52Neutral
  3. CCI-100.58Oversold
  4. ROC 25-24.61Bearish
  5. ROC 50-11.35Bearish
  6. Stoch K33.36Neutral
  7. Stoch D36.01Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper530.76Neutral
  3. BB Middle418.42Neutral
  4. BB Lower306.07Neutral
  5. ATR71.69Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI72.69Neutral